Interface Biologics is a commercial stage company that develops innovative materials for improving the efficacy of medical devices and targeted delivery of drugs.
Our surface modification additives are used in FDA-cleared medical devices and are clinically proven to reduce infection and thrombus-related complications.
Our sustained local drug delivery technology is applicable across a range of drug classes and medical specialties with an initial focus on ophthalmology.
We are located in the MaRS Discovery District
Interface Biologics, Inc.
MaRS Centre, South Tower
101 College Street, Suite 300
Toronto, ON, M5G 1L7
Main Line (416) 673-8170
Fax (416) 977-1329
info@interfacebiologics.com